POT1 and metastatic melanoma: One patient (NLCT group, deceased secondary to lung adenocarcinoma) had a history of metastatic lung adenocarcinoma, concurrent with their SS diagnosis, and one patient had a history of metastatic melanoma concurrent with their SS diagnosis and preceding chronic lymphocytic leukemia (POT-1 mutation, LCT group, deceased secondary to metastatic melanoma).